Literature DB >> 3625038

Dietary fat inhibits the intestinal metabolism of the carcinogen benzo[a]pyrene in fish.

P A Van Veld, R D Vetter, R F Lee, J S Patton.   

Abstract

Following the intestinal absorption of dietary benzo[a]pyrene (BP) by the killifish, this compound becomes incorporated along with dietary triglycerides into membrane-bound fat vacuoles within the intestinal epithelial cell (1985. J. Lipid Res. 26: 428-434). These vacuoles, arising from the smooth endoplasmic reticulum, are important transient structures involved in both the uptake and metabolism of dietary BP and, presumably, other lipophilic toxicants as well. In the present study we used subcellular fractions isolated from the intestines of spot (Leiostomus xanthurus), a teleost fish, to study factors that influence the metabolism of BP in a fat vacuole/microsomal system. Triglyceride-solubilized BP is capable of diffusion from fat vacuoles to microsomal enzymes. Increases in the concentration of fat vacuoles decrease the availability of BP to microsomal BP hydroxylase. The effect of fat vacuoles on the activity of BP hydroxylase becomes more pronounced as the concentration of BP in our test system decreases. Addition of cytosolic glutathione transferases to the fat vacuole/microsomal system enhances the activity of BP hydroxylase. Examination of binding of 3H-labeled BP to killifish (Fundulus heteroclitus) intestinal cytosolic proteins in vivo indicated that a large fraction of the radioactivity was associated within glutathione transferase. These results suggest that dietary fat inhibits metabolism of low levels of BP in the intestine. A consequence of this would be greater exposure of peripheral tissues to dietary carcinogens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3625038

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Immunohistochemical distribution of cytochrome P4501A in larvae and fingerlings of the Siberian sturgeon, Acipenser baeri.

Authors:  C Sarasquete; J B Ortiz; E Gisbert
Journal:  Histochem J       Date:  2001-02

2.  Prepregnancy body mass index, smoking during pregnancy, and infant birth weight.

Authors:  Michele La Merrill; Cheryl R Stein; Philip Landrigan; Stephanie M Engel; David A Savitz
Journal:  Ann Epidemiol       Date:  2011-03-21       Impact factor: 3.797

3.  Improvement of Oral Bioavailability of N-251, a Novel Antimalarial Drug, by Increasing Lymphatic Transport with Long-Chain Fatty Acid-Based Self-Nanoemulsifying Drug Delivery System.

Authors:  Chikako Imada; Takuma Takahashi; Makoto Kuramoto; Kazufumi Masuda; Ken-Ichi Ogawara; Akira Sato; Yusuke Wataya; Hye-Sook Kim; Kazutaka Higaki
Journal:  Pharm Res       Date:  2015-02-27       Impact factor: 4.200

4.  Glutathione S-transferase in intestine, liver and hepatic lesions of mummichog (Fundulus heteroclitus) from a creosote-contaminated environment.

Authors:  P A Van Veld; U Ko; W K Vogelbein; D J Westbrook
Journal:  Fish Physiol Biochem       Date:  1991-12       Impact factor: 2.794

5.  Immunohistochemical localization of cardio-active neuropeptides in the heart of a living fossil, Nautilus pompilius L. (Cephalopoda, Tetrabranchiata).

Authors:  J Springer; P Ruth; K Beuerlein; B Westermann; R Schipp
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

6.  Bioavailability and biotransformation of benzo(a)pyrene in an isolated perfused In situ catfish intestinal preparation.

Authors:  K M Kleinow; M O James; Z Tong; C S Venugopalan
Journal:  Environ Health Perspect       Date:  1998-03       Impact factor: 9.031

Review 7.  Intestinal lymphatic transport for drug delivery.

Authors:  Jaime A Yáñez; Stephen W J Wang; Ian W Knemeyer; Mark A Wirth; Kevin B Alton
Journal:  Adv Drug Deliv Rev       Date:  2011-06-13       Impact factor: 15.470

Review 8.  Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.

Authors:  Natalie L Trevaskis; William N Charman; Christopher J H Porter
Journal:  Adv Drug Deliv Rev       Date:  2007-11-07       Impact factor: 15.470

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.